Clinical Research Directory
Browse clinical research sites, groups, and studies.
Combined Effects of Withania Somnifera & Syzgium Cumini on Hyperlipidemia
Sponsor: Riphah International University
Summary
Withania somnifera and Syzygium cumini are known for their potential therapeutic effects, particularly in managing lipid disorders. This study was aimed to provide valuable insights into their separate and synergistic effect of Withania somnifera (Ashwagandha) and Syzygium cumini (Jamun) on hyperlipidemic patients. The study included 60 patients, equally divided into four groups. Pre- and post-treatment assessments were conducted over 3 months. Each group recieved different treatment. Data was analyzed using SPSS version 21 through paired sample t-test. The findings of the research showed that Withania somnifera showed significant improvement in improving lipid profile and associated factors and concluded that the combination may be an effective and safe approach for managing hyperlipidaemia due to its beneficial impact on lipid profile.
Official title: Combined Effect of Withania Somnifera and Syzygium Cumini on Hyperlipidemic Patients
Key Details
Gender
All
Age Range
25 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2023-05-24
Completion Date
2023-10-25
Last Updated
2026-05-11
Healthy Volunteers
Yes
Conditions
Interventions
Atorvastatin 10mg
In this intervention, participants were instructed to take their usual medication for hyperlipidemia they were taking before.
Group B (treatment group 1)
In this intervention, participants were instructed to take Withania somnifera (500mg) twice a day (BD).
Group C (treatment group 2)
In this intervention, participants were instructed to take Syzgium cumini (500mg) twice a day (BD).
Group D (treatment group 3)
In this intervention, participants were instructed to take both Withania somnifera and Syzgium cumini (1000 mg) once a day (QD).
Locations (1)
Dr. Imran Hussain
Lahore, Punjab Province, Pakistan